1. Home
  2. WGS vs NGVT Comparison

WGS vs NGVT Comparison

Compare WGS & NGVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WGS
  • NGVT
  • Stock Information
  • Founded
  • WGS 2017
  • NGVT 1964
  • Country
  • WGS United States
  • NGVT United States
  • Employees
  • WGS N/A
  • NGVT N/A
  • Industry
  • WGS Retail: Computer Software & Peripheral Equipment
  • NGVT Major Chemicals
  • Sector
  • WGS Technology
  • NGVT Industrials
  • Exchange
  • WGS Nasdaq
  • NGVT Nasdaq
  • Market Cap
  • WGS 2.4B
  • NGVT 2.1B
  • IPO Year
  • WGS N/A
  • NGVT N/A
  • Fundamental
  • Price
  • WGS $118.15
  • NGVT $55.41
  • Analyst Decision
  • WGS Strong Buy
  • NGVT Buy
  • Analyst Count
  • WGS 7
  • NGVT 2
  • Target Price
  • WGS $102.14
  • NGVT $58.00
  • AVG Volume (30 Days)
  • WGS 488.0K
  • NGVT 221.8K
  • Earning Date
  • WGS 10-28-2025
  • NGVT 10-29-2025
  • Dividend Yield
  • WGS N/A
  • NGVT N/A
  • EPS Growth
  • WGS N/A
  • NGVT N/A
  • EPS
  • WGS 0.05
  • NGVT N/A
  • Revenue
  • WGS $362,321,000.00
  • NGVT $1,324,800,000.00
  • Revenue This Year
  • WGS $36.01
  • NGVT N/A
  • Revenue Next Year
  • WGS $19.01
  • NGVT $2.69
  • P/E Ratio
  • WGS $2,443.51
  • NGVT N/A
  • Revenue Growth
  • WGS 48.70
  • NGVT N/A
  • 52 Week Low
  • WGS $54.14
  • NGVT $28.49
  • 52 Week High
  • WGS $136.00
  • NGVT $60.77
  • Technical
  • Relative Strength Index (RSI)
  • WGS 48.57
  • NGVT 51.45
  • Support Level
  • WGS $115.01
  • NGVT $52.58
  • Resistance Level
  • WGS $125.77
  • NGVT $55.20
  • Average True Range (ATR)
  • WGS 7.43
  • NGVT 1.54
  • MACD
  • WGS -0.32
  • NGVT 0.00
  • Stochastic Oscillator
  • WGS 49.64
  • NGVT 58.47

About WGS GeneDx Holdings Corp.

GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.

About NGVT Ingevity Corporation

Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The Company generates the majority of its revenue from North America.

Share on Social Networks: